table of contents table of contents

Trichomoniasis is perhaps the most common curable sexually transmitted disease worldwide, yet …

Home » Biology Articles » Protistology » Protozoology » Trichomoniasis » References

- Trichomoniasis

Abraham, M., C. M. Desjardins, L. G. Filion, and G. E. Garber. 1996. Inducible immunity to Trichomonas vaginalis in a mouse model of vaginal infection. Infect. Immun. 64:3571-3575. [PubMed].
Addis, M., P. Rappelli, A. M. Pinto De Andrade, F. M. Rita, M. M. Colombo, P. Cappuccinelli, and P. L. Fiori. 1999. Identification of Trichomonas vaginalis alpha-actinin as the most common immunogen recognized by sera of women exposed to the parasite. J. Infect. Dis. 180:1727-1730. [PubMed].
Alderete, J., K. A. Wendel, A. M. Rompalo, E. J. Erbelding, M. Benchimol, and T. H. Chang. 2003. Trichomonas vaginalis: evaluating capsid proteins of dsRNA viruses and dsRNA virus within patients attending a sexually tranmitted disease clinic. Exp. Parasitol. 103:44-50. [PubMed].
Alderete, J. F., R. Arroyo, and M. W. Lehker. 1995. Analysis for adhesins and specific cytoadhesion of Trichomonas vaginalis. Methods Enzymol. 253:407-414. [PubMed].
Alderete, J. F., J. L. OBrien, R. Arrayo, et al. 1995. Cloning and molecular characterization involved in Trichomonas vaginalis cytoadherence. Mol. Microbiol. 17:69-83. [PubMed].
Arroyo, R., J. Engbring, and J. Alderete. 1992. Molecular basis of host epithelial cell recognition by Trichomonas vaginalis. Mol. Microbiol. 6:853-862. [PubMed].
Arroyo, R., A. Gonzalez-Robles, A. Martinez-Palomo, and J. F. Alderete. 1993. Trichomonas vaginalis for amoeboid transformation and adhesion synthesis follows cytoadherence. Mol. Microbiol. 7:299-309. [PubMed].
Bachmann, L., I. Lewis, R. Allen, J. Schwebke, L. Leviton, H. Siegal, and E. Hook III. 2000. Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility. Am. J. Public Health 90:1615-1618. [PubMed].
Bessarab, I., H. W. Liu, C. F. Ip, and J. H. Tai. 2000. The complete cDNA sequence of a type II Trichomonas vaginalis virus. Virology 267:350-359. [PubMed].
Bradley, P., C. J. Lahti, E. Plumper, and P. J. Johnson. 1997. Targeting and translocation of proteins in to the hydrogenosome of the protist Trichomonas: similarites with mitochondrial protein import. EMBO J. 16:3484-3493. [PubMed].
Briselden, A. M., and S. H. Hillier. 1994. Evaluation of Affirm VP microbial identification test for Gardnerella vaginalis and Trichomonas vaginalis. J. Clin. Microbiol. 32:148-152. [PubMed].
Briselden, A. M., B. J. Moncla, C. E. Stevens, and S. L. Hillier. 1992. Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis- associated microflora. J. Clin. Microbiol. 30:663-666. [PubMed].
Burgess, D. 1998. Trichomonads and intestinal flagellates, p. 203-214. In F. Cox, J. P. Krier, and D. Wakelin (ed.), Topley and Wilson's microbiology and microbial infections, 9th ed. University Press, New York, N.Y.
Burgess, D., K. F. Knoblock, T. Daugherty, and N. P. Robertson. 1990. Cytotoxic and hemolytic effects of Tritrichomonas foetus on mammalian cells. Infect. Immun. 58:3627-3632. [PubMed].
Burgess, D., and K. F. Knoblock. 1989. Identification of Tritrichomonas foetus in sections of bovine placental tissue with monoclonal antibodies. J. Parasitol. 75:977-980. [PubMed].
Burgess, D., and C. M. McDonald. 1992. Analysis of adhesion and cytotoxicity of Tritrichomonas foetus to mammalian cells by use of monoclonal antibodies. Infect. Immun. 60:4253-4259. [PubMed].
Cates, W., and The American Social Health Association Panel. 1999. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex. Transm. Dis. 26:52-57.
Centers for Disease Control and Prevention. 2002. 2002 Sexually transmitted diseases treatment Guidelines. Morb. Mortal. Wkly. Rep. 51:(RR-6):44-45.
Coombs, G., G. D. Westrop, P. Suchan, G. Puzova, R. P. Hirt, T. M. Embley, J. C. Mottram, and S. Muller. 2004. The amitochondrial eukaryote Trichomonas vaginalis contains a divergent thioredoxin-linked peroxiredoxin antioxidant system. J. Biol. Chem. 279:5249-5256. [PubMed].
Cotch, M. F., J. G. Pastorek, R. P. Nugent, S. L. Hillier, R. S. Gibbs, D. H. Martin, D. A. Eschenbach, R. Edelman, J. C. Carey, J. A. Reegan, M. A. Krohn, M. A. Klebanoff, A. V. Rao, and G. G. Rhoads. 1997. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex. Transm. Dis. 24:361-362. [PubMed].
Cu-Uvin, S., H. Ko, J. W. Jamieson, Hogan, P. Schuman, J. Anderson, R. S. Klein, and the HIV Epidemiology Research Study (HERS) Group. 2002. Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection. Clin. Infect. Dis. 34:1406-1411. [PubMed].
Draper, D., W. Donohoe, L. Mortimer, and R. P. Heine. 1998. Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor. J. Infect. Dis. 178:815-819. [PubMed].
Draper, D., D. V. Landers, M. A. Krohn, S. L. Hillier, H. C. Wieseneld, and R. P. Heine. 2000. Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am. J. Obstet. Gynecol. 183:1243-1248. [PubMed].
Draper, D., R. Parker, E. Patterson, W. Jones, M. Beutz, J. French, K. Borchardt, and J. McGregor. 1993. Detection of Trichomonas vaginalis in pregnant women with the InPouch TV system. J. Clin. Microbiol. 31:1016-1018. [PubMed].
Dyall, S., and P. J. Johnson. 2000. Origins of hydrogenosomes and mitochondria: evolution and organelle biogenesis. Curr. Opin. Microbiol. 3:404-411. [PubMed].
Dyer, B. 1990. Phylum Zoomastigina Class Parabasalia, p. 252-258. In L. Margulis, J. O. Corliss, M. Melkonian, and D. J. Chapman (ed.), Handbook of Protoctista. Jones and Bartlett, Boston, Mass.
Engbring, J., and J. F. Alderete. 1998. Characterization of Trichomonas vaginalis AP33 adhesin and cell surface interactive domains. Microbiology 144:3011-3018. [PubMed].
Fais, S., and W. Malorni. 2003. Leukocycte uropod formation and membrane/cytoskeleton linkage in immune interactions. J. Leukoc. Biol. 73:556-563.
Fiori, P., P. Rappelli, A. Rocchigiani, and P. Cappuccinelli. 1993. Trichomonas vaginalis haemolysis: evidence of functional pores formation on red cell membranes. FEMS Microbiol. Lett. 13-18. [PubMed].
Fiori, P., M. F. Rappelli, and M. F. Addis. 1999. The flagellated parasite Trichomonas vaginalis: new insights into cytopathogenicity mechanisms. Microb. Pathog. 1:149-156.
Fouts, A. C., and S. J. Kraus. 1980. Trichomonas vaginalis: re-evaluation of its clinical presentation and laboratory diagnosis. J. Infect. Dis. 141:137-143. [PubMed].
Garber, G. E., L. T. Lemchuk-Favel, and W. R. Bowie. 1989. Isolation of a cell-detaching factor of Trichomonas vaginalis. J. Clin. Microbiol. 27:1548-1553. [PubMed].
Gilbert, R., G. Elia, D. H. Beach, S. Klaessig, and B. N. Singh. 2000. Cytopathogenic effect of Trichomonas vaginalis on human vaginal epithelial cells cultured in vitro. Infect. Immun. 68:4200-4206. [PubMed].
Reference deleted.
Hamed, K., and A. Studemeister. 1992. Successful response of metronidazole-resistant trichomonal vaginitis to tinidazole. Sex. Transm. Dis. 19:339-340. [PubMed].
Hardy, P., J. Hardy, E. Nell, and D. Graham. 1984. Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome. Lancet ii:333-337.
Heine, R. P., H. C. Wiensfeld, R. L. Sweet, and S. S. Witkin. 1997. Polymerase chain reaction analysis of distal vaginal specimens: a less invasive strategy for detection of Trichomonas vaginalis. Clin. Infect. Dis. 24:985-987. [PubMed].
Hesseltine, H. 1942. Experimental human vaginal trichomoniasis. J. Infect. Dis. 71:127.
Hillier, S. L., S. S. Wilken, M. A. Krohn, D. H. Watts, N. B. Kiviat, and D. A. Eschenbach. 1993. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis and chorioamnion infection. Obstet. Gynecol. 81:941-948. [PubMed].
Hobbs, M., P. Kazembe, A. Reed, W. Miller, and E. Nkata. 1999. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex. Transm. Dis. 26:381-387. [PubMed].
Honigberg, B., and D. E. Burgess. 1994. Trichomonads of importance in human medicine including Dientamoeba fragilis, p. 1-109. In J. P. Kreier (ed.), Parasitic protozoa, vol. 9. Academic Press, Inc., New York, N.Y.
Honigberg, B., and V. M. King. 1964. Structure of Trichomonas vaginalis Donne. J. Parasitol. 50:345-364. [PubMed].
Hook, R. J., M. St. Claire, L. K. Riley, C. I. Franklin, and C. L. Besch-Williford. 1997. Mouse strain and age affect susceptibility to experimentally induced genital trichomoniasis. Lab. Anim. Sci. 47:324-326. [PubMed].
James, J. A., J. L. Thomason, S. M. Gelbart, P. Osypowski, P. Kaiser, and L. Hanson. 1992. Is trichomoniasis often associated with bacterial vaginosis in pregnant adolescents? Am. J. Obstet. Gynecol. 166:859-863. [PubMed].
Jeremias, J., D. Draper, M. Ziegert, et al. 1994. Detection of Trichomonas vaginalis using the polymerase chain reaction in pregnant and non-pregnant women. Infect. Dis. Obstet. Gynecol. 2:16-19.
Joyner, J., J. Douglas, S. Ragsdale, M. Foster, and F. Judson. 2000. Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic. Sex. Transm. Dis. 27:236-240. [PubMed].
Katiyar, S. K., and T. D. Edlind. 1994. β-Tubulin genes of Trichomonas vaginalis. Mol. Biochem. Parasitol. 64:33-42. [PubMed].
Kaydos-Daniels, S., W. C. Miller, I. Hoffman, T. Banda, W. Dzinyemba, F. Martinson, M. S. Cohen, and M. M. Hobbs. 2003. Validation of a urine-based PCR-enzyme-linked immunosorbent assay for use in clinical reseach settings to detect Trichomonas vaginalis in men. J. Clin. Microbiol. 41:318-323. [PubMed].
Kengne, P., F. Veas, N. Vidal, J. L. Rey, and G. Cuny. 1994. Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis. Cell. Mol. Biol. 40:819-831.
Khoshnan, A., and J. F. Alderete. 1994. Trichomonas vaginalis with a double-stranded RNA virus has upregulated levels of phenotypically variable immunogen mRNA. J. Virol. 68:4035-4038. [PubMed].
Kigozi, G., H. Brahmbhatt, F. Wabwire-Mangen, M. J. Wawer, D. Serwaqdda, N. Sewankambo, and R. H. Gray. 2003. Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai, Uganda. Am. J. Obstet. Gynecol. 189:1398-1400. [PubMed].
Klebanoff, M., J. Carey, J. Hauth, S. L. Hillier, R. Nugent, E. Thom, J. Ernest, R. Heine, R. Wapner, W. Trout, A. Moawad, K. Leveno, M. Miodovnik, B. Sibai, J. Van Dorsten, M. Dombrowski, M. O'Sullivan, M. Varner, O. Langer, D. McNellis, and J. Roberts. 2001. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N. Engl. J. Med. 345:487-493. [PubMed].
Klouman, E., E. J. Massenga, K. I. Klepp, N. E. Sam, W. Nkya, and C. Nlya. 1997. HIV and reproductive tract infections in a total village population in rural Kilimanjaro, Tanzania: women at increased risk. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14:163-168. [PubMed].
Krieger, J., J. I. Ravdin, and M. F. Rein. 1985. Contact-dependent cytopathogenic mechanisms of Trichomonas vaginalis. Infect. Immun. 50:778-786. [PubMed].
Krieger, J. N., M. R. Tam, C. E. Stevens, I. O. Nielsen, J. Hale, N. B. Kiviat, and K. K. Holmes. 1988. Diagnosis of trichomoniasis. JAMA 259:1223-1227. [PubMed].
Krieger, J. N., M. Verdon, N. Siegel, and K. K. Holmes. 1993. Natural history of urogenital trichomoniasis in men. J. Urol. 149:1455-1458. [PubMed].
Kurth, A., W. L. H. Whittington, M. R. Golden, K. K. Thomas, K. K. Holmes, and J. Schwebke. 2004. Performance of a new, rapid assay for detection of Trichomonas vaginalis. J. Clin. Microbiol. 42:2940-2943. [PubMed].
Laga, M., A. Manoka, M. Kivuvu, B. Malele, M. Tuliza, N. Nzila, J. Goeman, F. Behets, V. Batter, and M. Alary. 1993. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 7:95-102. [PubMed].
Land, K., M. G. Delgadillo-Correa, J. Tachezy, S. Vanacova, C. L. Hsieh, R. Sutak, and P. J. Johnson. 2004. Targeted gene replacement of a ferredoxin gene in Trichomonas vaginalis does not lead to metronidazole resistance. Mol. Microbiol. 51:115-122. [PubMed].
Lawing, L., S. Hedges, and J. Schwebke. 2000. Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR. J. Clin. Microbiol. 38:3585-3588. [PubMed].
Leon-Sicairos, C., J. Leon-Felix, and R. Arroyo. 2004. tvcp12: a novel Trichomonas vaginalis cathepsin L-like cystein proteinase-encoding gene. Microbiology 150:1131-1138. [PubMed].
Leroy, V., A. De Clercq, J. Ladner, J. Bogaerts, P. Van de Perre, and F. Dabis. 1995. Should screening of genital infections be part of antenatal care in areas of high HIV prevalence? A prospective cohort study from Kigali, Rwanda, 1992-1993. Genitourin. Med. 71:207-211. [PubMed].
Lindmark, D., and M. Muller. 1973. Hydrogenosome, a cytoplasmic organelle of the anaerobic flagellate Tritrichomonas foetus, and its role in pyruvate metabolism. J. Biol. Chem. 248:7724-7728. [PubMed].
Lockwood, B., M. J. North, K. I. Scott, A. F. Bremner, G. H. Coombs. 1987. The use of a highly sensitive electophoretic method to compare the proteinases of trichomonads. Mol. Biochem. Parasitol. 24:89-95. [PubMed].
Lockwood, B., M. J. North, and G. H. Coombs. 1984. Trichomonas vaginalis. Tritrichomonas foetus, and Trichomitus batrachorum: comparative proteolytic activity. Exp. Parasitol. 58:245-253. [PubMed].
Lossick, J. 1980. Single-dose metronidazole treatment for vaginal trichomoniasis. Obstet. Gynecol. 56:508-510. [PubMed].
Lossick, J. G. 1989. Epidemiology of urogenital trichomoniasis, p. 311-323. In B. M. Honigberg (ed.), Trichomonads parasitic in humans. Springer-Verlag, New York, N.Y.
Lossick, J. G., M. Muller, and T. E. Gorrell. 1986. In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J. Infect. Dis. 153:948-955. [PubMed].
Lubick, K., and D. E. Burgess. 2004. Purification and analysis of phospholipaseA2-like lytic factor of Trichomonas vaginalis. Infect. Immun. 72:1284-1290. [PubMed].
Lushbaugh, W., A. C. Turner, G. A. Gentry, and P. C. Klykken. 1989. Characterization of a secreted cytoactive factor from Trichomonas vaginalis. Am. J. Trop. Med. Hyg. 41:18-28.
Madico, G., T. C. Quinn, A. Rompalo, K. T. McKee, Jr., and C. A. Gaydas. 1998. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J. Clin. Microbiol. 36:3205-3210. [PubMed].
Mallinson, D. J., B. C. Lockwood, G. H. Coombs, and M. J. North. 1994. Identification and molecular cloning of four cysteine proteinase genes from the pathogenic protozoon Trichomonas vaginalis. Microbiology 140:2725-2735. [PubMed].
Mason, P., and B. A. Patterson. 1985. Proliferative response of human lymphocytes to secretory and cellular antigens of Trichomonas vaginalis. J. Parasitol. 71:265-268. [PubMed].
McGregor, J. A., J. I. Franch, W. Jones, R. Parker, E. Patterson, and D. Draper. 1992. Association of cervicovaginal infections with increased vaginal fluid phospholipase A2 activity. Am. J. Obstet. Gynecol. 167:1588-1594. [PubMed].
Mendoza-Lopez, M., C. Becerril-Garcia, L. V. Fattel-Facenda, L. Avila- Gonzalez, M. E. Ruiz-Tachiquin, J. Ortega-Lopez, and R. Arroyo. 2000. CP30, a cysteine proeinase involved in Trichomonas vaginalis cytoadherence. Infect. Immun. 68:4907-4912. [PubMed].
Minkoff, H., A. N. Grunebaum, R. H. Schwarz, J. Feldman, M. Cummings, M. Crombleholme, and W. Clark. 1984. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am. J. Obstet. Gynecol. 150:965-972. [PubMed].
Mitchell, M. D., D. W. Branch, S. Lundin-Schiller, R. J. Romero, R. A. Daynes, and D. J. Dudley. 1991. Immunologic aspects of preterm labor. Semin. Perinatol. 15:210-224. [PubMed].
Mutwiri, G., and L. B. Corbeil. 1998. Genital and systemic immune responses in a murine model of Tritrichomonas foetus infection. J. Parasitol. 84:321-327. [PubMed].
Niccolai, L., J. J. Kopicko, A. Kassie, H. Petros, R. A. Clark, and P. Kissinger. 2000. Incidence and predictors of reinfection with Trichomonas vaginalis in HIV-infected women. Sex. Transm. Dis. 27:284-288. [PubMed].
Nielsen, M. 1976. In vitro effect of metronidazole on the ultrastructure of Trichomonas vaginalis Donne. Acta Pathol. Microbiol. Scand. Sect. B 84:93-100. [PubMed].
Nielsen, M., and R. Nielsen. 1975. Electron microscopy of Trichomonas vaginalis Donne: interaction with vaginal epithelium in human trichomoniasis. Acta Pathol. Microbiol. Scand. Sect. B 83:305-320. [PubMed].
North, M., C. D. Robertson, and G. H. Coombs. 1990. The specificity of trichomonad proteinases analyzed using fluorogenic substrates and specific inhibitors. Mol. Biochem. Parasitol. 39:183-194. [PubMed].
Paces, J., V. Urbankova, and P. Urbanek. 1992. Cloning and characterization of a repetitive DNA sequence specific for Trichomonas vaginalis. Mol. Biochem. Parasitol. 54:247-256. [PubMed].
Parsonson, I., B. I. Clark, and J. H. Duffy. 1976. Early pathogenesis and pathology of Tritrichomonas foetus infection in virgin heifers. J. Comp. Pathol. 86:59-66. [PubMed].
Paterson, B. A., S. N. Tabrizi, S. M. Garland, C. K. Fairley, and F. J. Bowden. 1998. The tampon test for trichomoniasis: a comparison between conventional methods and a polymerase chain reaction for Trichomonas vaginalis in women. Sex. Transm. Infect. 74:136-139. [PubMed].
Pearlman, M., C. Yashar, S. Ernst, and W. Solomon. 1996. An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reactions to metronidazole. Am. J. Obstet. Gynecol. 174:934-936. [PubMed].
Platz-Christensen, J. J., I. Mattsby-Baltzer, P. Thomsen, and N. Wiqvist. 1993. Endotoxin and interleukin-1 alpha in the cervical mucus and vaginal fluid of pregnant women with bacterial vaginosis. Am. J. Obstet. Gynecol. 169:1161-1166. [PubMed].
Price, M., D. Zimba, I. F. Hoffman, S. C. Kaydos-Daniels, W. C. Miller, F. Martinson, D. Chilongozi, E. Kip, E. Msowoya, M. M. Hobbs, P. N. Kazembe, and M. S. Cohen. 2003. Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial. Sex. Transm. Dis. 30:516-522. [PubMed].
Rein, M. F., and M. Muller. 1990. Trichomonas vaginalis and trichomoniasis. Sex. Transm. Dis. 481-492.
Reynolds, J. (ed.). 1996. Martindale: the extra pharmacopoeia, 21st ed., p. 632-633. Royal Pharmaceutical Society, London, United Kingdom.
Rhyan, J., K. L. Wilson, D. E. Burgess, L. L. Stackhouse, and W. J. Quinn. 1995. Immunohistochemical detection of Tritrichomonas foetus in formalin-fixed, paraffin-embedded sections of bovine placenta and fetal lung. J. Vet. Diagn. Investig. 7:98-101. [PubMed].
Riley, D. E., M. C. Roberts, T. Takayama, and J. N. Krieger. 1992. Development of a polymerase chain reaction based diagnosis of Trichomonas vaginalis. J. Clin. Microbiol. 30:465-472. [PubMed].
Roe, F. 1985. Safety of nitroimidazoles. Scand. J. Infect. Dis. Suppl. 46:72-81. [PubMed].
Ryu, J., H. Chung, D. Min, Y. Cho, Y. Ro, and S. Kim. 1999. Diagnosis of trichomoniasis by polymerase chain reaction. Yonsei Med. J. 40:56-60. [PubMed].
Saurina, G., L. DeMao, and W. McCormack. 1998. Cure of metronidazole- and tinidazole-resistant trichomoniasis with the use of high-dose oral and intravaginal tinidazole. Clin. Infect. Dis. 26:
Sawyer, P., R. N. Brogden, R. M. Pinder, T. M. Speight, and G. S. Avery. 1976. Tinidazole: a review of its antiprotozoal activity and therapeutic efficacy. Drugs 11:423-440. [PubMed].
Schee, C., A. Belkum, L. Zwijgers, et al. 1999. Improved diagnosis of Trichomonas vaginalis infection by PCR using vaginal swabs and urine specimens compared to diagnosis by wet mount microscopy, culture, and fluorescent staining. J. Clin. Microbiol. 37:4127-4130. [PubMed].
Schmid, G., E. Narcisi, D. Mosure, and E. Secor. 2001. Prevalence of metronidazole resistant Trichomonas vaginalis in a gynecology clinic. J. Reprod. Med. 46:545. [PubMed].
Schwebke, J., and E. I. Hook. 2003. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J. Infect. Dis. 188:465-468. [PubMed].
Schwebke, J., and L. Lawing. 2002. Improved detection by DNA amplification of Trichomonas vaginalis in males. J. Clin. Microbiol. 40:3681-3683. [PubMed].
Schwebke, J., M. Venglarik, and S. Morgan. 1999. Delayed versus immediate bedside inoculation of culture media for diagnosis of vaginal trichomonosis. J. Clin. Microbiol. 37:2369-2370. [PubMed].
Schwebke, J. R., S. C. Morgan, and G. B. Pinson. 1997. Validity of self obtained vaginal specimens for diagnosis of trichomoniasis. J. Clin. Microbiol. 35:1618-1619. [PubMed].
Shaio, M. P. R. Lin, and J. Y. Liu. 1997. Colorimetric one-tube nested PCR for detection of Trichomonas vaginalis in vaginal discharge. J. Clin. Microbiol. 35:132-138. [PubMed].
Silva-Filho, F., S. Kasai, M. Nomizu, L. B. Lopez, M. B. Melo-Braga, B. Rocha-Azevedo, D. B. Petropolis, and I. S. Horbach. 2002. How laminin-1 can be recognized by the protozoan parasite Tritrichomonas foetus: possible role played by the extracellular matrix glycoprotein in both cytoadhesion and cytotoxicity exerted by the parasite. Parasitol. Int. 51:305-307. [PubMed].
Skirrow, S. Z., and R. H. BonDurant. 1988. Bovine trichomoniasis. Vet. Bull. 58:591-603.
Sobel, J., V. Nagappan, and P. Nyirjesy. 1999. Metronidazole-resistant vaginal trichomoniasis: an emerging problem. N. Engl. J. Med. 341:292-293. [PubMed].
Sobel, J., P. Nyirjesy, and W. Brown. 2001. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin. Infect. Dis. 33:1341-1346. [PubMed].
Sorvillo, F., and P. Kerndt. 1998. Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet 351:213-214.
Thomason, J. L., S. M. Gelbart, J. F. Sobun, M. B. Schulien, and P. R. Hamilton. 1988. Comparison of four methods to detect Trichomonas vaginalis. J. Clin. Microbiol. 26:1869-1870. [PubMed].
Tsai, C., H. W. Liu, and J. H. Tai. 2002. Characterization of an iron-responsive promoter in the protozoan pathogen Trichomonas vaginalis. J. Biol. Chem. 277:5153-5162. [PubMed].
Van Andel, R., C. L. Franklin, M. C. St. Claire, L. K. Riley, C. L. Besch- Williford, and R. R. Hook. 1996. Lesions of experimental genital Tritrichomonas foetus infections in estrogenized BALB/c mice. Vet. Pathol. 33:407-411. [PubMed].
Viscogliosi, E., V. P. Edgcomb, D. Gerbod, C. Noel, and P. Delgado-Viscogliosi. 1999. Molecular evolution inferred from small subunit rRNA sequences: what does it tell us about phylogenetic relationships and taxonomy of the parabasalids? Parasite 6:279-291. [PubMed].
Voolman, T., and P. Boreham. 1993. Metronidazole resistant Trichomonas vaginalis in Brisbane. Med. J. Aust. 159:490.
Wang, A., C. C. Wang, and J. F. Alderete. 1987. Trichomonas vaginalis phenotypic variation occurs only among trichomonads infected with the double-stranded RNA virus. J. Exp. Med. 166:142-150. [PubMed].
Wang, A., and C. C. Wang. 1986. The double-stranded RNA in Trichomonas vaginalis may originate from virus-like particles. Proc. Natl. Acad. Sci. USA 83:7956-7960. [PubMed].
Weber, B., T. M. Mapeka, M. A. Maahlo, and A. A. Hoosen. 2003. Double stranded RNA virus in South African Trichomonas vaginalis isolates. J. Clin. Pathol. 56:542-543. [PubMed].
Weinstock, H., S. Berman, and W. Cates. 2004. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect. Sex. Reprod. Health 36:6-10.
Wiese, W., S. R. Patel, S. C. Patel, C. A. Ohl, and C. A. Estrada. 2000. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am. J. Med. 108:301-308. [PubMed].
Wilcox, R. 1960. Epidemiological aspects of human trichomoniasis. Br. J. Vener. Dis. 36:167. [PubMed].
Wølner-Hanssen, P., J. N. Krieger, C. E. Stevens, N. B. Kiviat, L. Koutsky, C. Critchlow, T. DeRouen, S. Hillier, and K. K. Holmes. 1989. Clinical manifestations of vaginal trichomoniasis. JAMA 261:571-576. [PubMed].
Wood, B., and A. Monroe. 1975. Pharmacokinetics of tinidazole and metronidazole after single large oral doses. Br. J. Vener. Dis. 51:51-53. [PubMed].
Wos, S., and R. M. Watt. 1986. Immunoglobulin isotypes of anti-Trichomonas vaginalis antibodies in patients with vaginal trichomoniasis. J. Clin. Microbiol. 24:790-795. [PubMed].

rating: 3.50 from 2 votes | updated on: 27 Sep 2007 | views: 14431 |

Rate article: